{"result": "(\"entity\"<|>LOPHELX LQ<|>ORGANIZATION<|>Lophelx LQ is a product used in dietary management for patients with MSUD, focusing on maintaining optimal leucine levels.)\n##\n(\"entity\"<|>MSUD MAXAMAID<|>ORGANIZATION<|>MSUD Maxamaid is a dietary product designed for individuals with Maple Syrup Urine Disease (MSUD) to help manage protein intake.)\n##\n(\"entity\"<|>MSUD MAXAMUM<|>ORGANIZATION<|>MSUD Maxamum is another dietary product aimed at patients with MSUD, assisting in the control of leucine levels.)\n##\n(\"entity\"<|>VITAFLO<|>ORGANIZATION<|>Vitaflo is a company that produces specialized dietary products for metabolic disorders, including MSUD.)\n##\n(\"entity\"<|>TIAMINA<|>ORGANIZATION<|>Tiamina is a supplement recommended for patients with MSUD to aid in their dietary management.)\n##\n(\"entity\"<|>BCAA<|>ORGANIZATION<|>BCAA refers to branched-chain amino acids, which are restricted in the diet of MSUD patients.)\n##\n(\"entity\"<|>POLÍMEROS DE GLUCOSA<|>ORGANIZATION<|>Polímeros de glucosa are used in dietary treatment to prevent catabolism in patients with metabolic disorders.)\n##\n(\"entity\"<|>MEAD-JOHNSON<|>ORGANIZATION<|>Mead-Johnson is a company that produces specialized nutritional products, including BCD 1 and 2 for metabolic disorders.)\n##\n(\"entity\"<|>PFD<|>ORGANIZATION<|>PFD is a type of hypercaloric supplement recommended for patients undergoing dietary restrictions.)\n##\n(\"entity\"<|>ENERGYVIT<|>ORGANIZATION<|>Energyvit is a hypercaloric supplement used in dietary management for patients with metabolic disorders.)\n##\n(\"entity\"<|>KCALIP<|>ORGANIZATION<|>Kcalip is a hypercaloric supplement that is used to support patients with dietary restrictions due to metabolic disorders.)\n##\n(\"entity\"<|>ALIMENTOS CON PNAVB<|>EVENT<|>Foods with PNAVB are excluded from the diet of MSUD patients due to their high leucine content.)\n##\n(\"entity\"<|>DESCOMPENSACIONES METABÓLICAS<|>EVENT<|>Metabolic decompensations occur in patients with MSUD during acute illnesses or immunizations, requiring dietary adjustments.)\n##\n(\"relationship\"<|>LOPHELX LQ<|>VITAFLO<|>Lophelx LQ is a product manufactured by Vitaflo for dietary management of MSUD patients<|>7)\n##\n(\"relationship\"<|>MSUD MAXAMAID<|>VITAFLO<|>MSUD Maxamaid is a product produced by Vitaflo for managing MSUD<|>7)\n##\n(\"relationship\"<|>MSUD MAXAMUM<|>VITAFLO<|>MSUD Maxamum is a product produced by Vitaflo for managing MSUD<|>7)\n##\n(\"relationship\"<|>TIAMINA<|>VITAFLO<|>Tiamina is a supplement recommended by Vitaflo for MSUD patients<|>6)\n##\n(\"relationship\"<|>BCAA<|>MSUD MAXAMAID<|>BCAA are restricted in the diet of patients using MSUD Maxamaid<|>5)\n##\n(\"relationship\"<|>BCAA<|>MSUD MAXAMUM<|>BCAA are restricted in the diet of patients using MSUD Maxamum<|>5)\n##\n(\"relationship\"<|>POLÍMEROS DE GLUCOSA<|>DESCOMPENSACIONES METABÓLICAS<|>Polímeros de glucosa are used to manage metabolic decompensations in patients<|>6)\n##\n(\"relationship\"<|>MEAD-JOHNSON<|>BCD 1<|>Mead-Johnson produces BCD 1, a product for dietary management<|>7)\n##\n(\"relationship\"<|>MEAD-JOHNSON<|>BCD 2<|>Mead-Johnson produces BCD 2, a product for dietary management<|>7)\n##\n(\"relationship\"<|>PFD<|>DESCOMPENSACIONES METABÓLICAS<|>PFD is recommended during metabolic decompensations<|>6)\n##\n(\"relationship\"<|>ENERGYVIT<|>DESCOMPENSACIONES METABÓLICAS<|>Energyvit is recommended during metabolic decompensations<|>6)\n##\n(\"relationship\"<|>KCALIP<|>DESCOMPENSACIONES METABÓLICAS<|>Kcalip is recommended during metabolic decompensations<|>6)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: 20-50                  30-60                120-145\n Lactantes                               2-3                   40-80                  20-50                  30-60                115-145\n Escolares                             1,5-2                   20-40                   5-15                  10-30                  60-80\n Adolescentes y adultos                  1-1,2                  5-15                   5-15                  10-30                  40-60\n---\n 312      BLOQUE: PROTEÍNAS Y AMINOÁCIDOS\n\n\n\n   Para conseguir un mejor pronóstico intelectual lo              Lophelx LQ 20, MSUD Maxamaid y MSUD Maxamum\nóptimo es mantener concentraciones de leucina por                 (SHS); Vitaflo MSUD gel, Vitaflo MSUD Express, Vitaflo\ndebajo de 200 μmol/l (2,6 mg/dl)17.                               MSUD Express Cooler (esta última en formato líquido)\n   En la dieta de los pacientes con MSUD se excluyen              de laboratorios Vitaflo.\nlos alimentos con PNAVB (carnes, pescado, huevos, le-               Se recomienda dar un suplemento de tiamina de\nche y derivados) debido a su alto contenido en leucina.           5 mg/kg/día para todas las formas de enfermedad, ya\nEsta será suministrada por alimentos con proteínas de             que está demostrado que puede beneficiar a estos pa-\nbajo valor biológico como patatas, verduras, hortalizas           cientes. Las formas tiamino-dependientes requieren\ny frutas (tabla 5).                                               entre 10-10000 mg/día.\n   La oferta de alimentos se ve limitada debido a los\nescasos datos de contenido de leucina de los alimen-              3.4.   Tratamiento dietético en las\ntos, principalmente de los manufacturados. Tampoco                       descompensaciones metabólicas\nes posible utilizar el contenido proteico del alimento\ncomo un indicador del contenido de leucina, pues es                 Suelen ocurrir durante procesos intercurrentes (en-\nmuy variable y poco fiable18.                                     fermedad aguda, inmunizaciones, etc.) y debemos es-\n   Esta restricción de proteínas naturales de la dieta            tar atentos a la posible aparición de síntomas con el\nobliga al empleo de suplementos proteicos libres de               objetivo de instaurar un tratamiento precoz.\nBCAA. La cantidad a administrar dependerá de la edad;               Este tratamiento consiste en la supresión de alimen-\nla mayoría de los estudios muestran aportes durante               tos proteicos y la administración de polímeros de glu-\nlos primeros meses de 2,5-3 g/kg, de los cuales, entre            cosa para evitar el catabolismo (tabla 6).\nun tercio y la mitad, son en forma de proteína natural              Estos preparados deben administrarse a bajo volu-\ny el resto en forma de fórmula especial exenta de                 men y alta frecuencia, preferentemente por vía oral o\nBCAA. La mayoría de estos preparados contienen vita-              sonda nasogástrica en caso de intolerancia oral17.\nminas y minerales que cubren las necesidades del pa-\nciente según la edad17.                                           3.5.   Tratamiento dietético en situaciones\n   Actualmente los preparados comerciales son los si-                    especiales\nguientes: BCD 1 y 2 (Mead-Johnson); MSUD Anamix\nInfant, MSUD Anamix Junior, MSUD Junior LQ, MSUD                    En caso de intervención quirúrgica programada es\n                                                                  aconsejable, en los 2-3 días previos a la intervención,\n           Contenido de BCAA por gramo de proteína17.             establecer    medidas     dietéticas    como     suspender  por\nTabla 5.                                                          completo el aporte de proteína natural de alto valor\n     Alimento           Leucina        Isoleucina        Valina   biológico, aumentar la fórmula exenta de BCAA y to-\n                                                                  mar suplementos hipercalóricos exentos de proteína\n  Carnes                 9-10%            6-7%            7-8%    (PFD, Energyvit, Kcalip, etc.).\n  Leche de vaca           10%             6-7%             7%       Se debe administrar glucosa por vía venosa y, si fue-\n                                                                  ra necesario, insulina.\n  Verduras                4-5%            3-4%             4%       Es aconsejable en el postoperatorio mantener 24-48\n  Patata                   7%               5%             6%     horas más estas medidas y reintroducir aporte proteico\n                                                                  pasadas estas horas.\n  Pastas, pan              8%               4%             5%\n  Mantequilla              8%               6%             7%     3.6.   Nuevas terapias\n  Frutas\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}